How should public policy respond to the challenges of modern biotechnology?

Modern biotechnology has been a topic of public and political debate around the world for over 30 years; continuing scientific breakthroughs keep it high on the agenda. Policy responses have been diverse, fragmented and incoherent, at levels ranging from local regions to agencies of the United Nations, but particularly in national administrations and the European Union. Reactions have been ambivalent, combining fears about conjectural risks with concern to maintain competitiveness and exploit beneficial applications. Adverse public perceptions have become a significant influence on policy, in combination with more cynical and self-interested motives of some of the players in policy debates. Future options, in Europe and elsewhere, are constrained by past and continuing mistakes and over-reactions.

[1]  Martin W. Bauer,et al.  Biotechnology in the public sphere: a European sourcebook. , 1998 .

[2]  G. MorelliGradi.  Patenting biotechnologies: the European Union Directive 98/44/EC of the European parliament and of the council of 6th July 1998 on the legal protection of biotechnological inventions. , 1999 .

[3]  A. Cropper.  Convention on Biological Diversity , 1993, Environmental Conservation.

[4]  Robert Carlson,et al.  The pace and proliferation of biological technologies. , 2003, Biosecurity and bioterrorism : biodefense strategy, practice, and science.

[5]  R. Phipps,et al.  Environmental benefits of genetically modified crops: Global and European perspectives on their ability to reduce pesticide use , 2002 .

[6]  Carl E. Correns,et al.  19. C. Correns: G. Mendel's Regel über das Verhalten der Nachkommenschaft der Rassenbastarde , 1900, Berichte der Deutschen Botanischen Gesellschaft.

[7]  Robert E. Evenson,et al.  Consumer purchasing behaviour towards GM foods in the Netherlands. , 2004 .

[8]  F. Crick,et al.  Molecular Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid , 1953, Nature.

[9]  George Gaskell,et al.  Europeans and biotechnology in 2002 - Eurobarometer 58.0 : A report to the EC Directorate General for Research from the project "Life Sciences in European Society" , 2003 .

[10]  O. Avery,et al.  STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES , 1944, The Journal of experimental medicine.

[11]  P. Berg,et al.  Potential biohazards of recombinant DNA molecules. , 1974, Science.

[12]  David A. Bohan,et al.  On the rationale and interpretation of the Farm Scale Evaluations of genetically modified herbicide-tolerant crops. , 2003, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[13]  Maxine Singer,et al.  Guidelines for DNA hybrid molecules. , 1973, Science.

[14]  I. Economidis,et al.  EC-sponsored research on safety of genetically modified organisms: a review of results. , 2001 .